NCT02704260 (GOSSER) is a NA clinical trial of GENETIC ANALYSIS in Genetic Syndrome, sponsored by University Hospital, Angers.

Who is sponsoring NCT02704260?

NCT02704260 is sponsored by University Hospital, Angers.

What drugs are being tested in NCT02704260?

Interventions in NCT02704260: GENETIC ANALYSIS.

What condition does NCT02704260 study?

NCT02704260 studies Genetic Syndrome.

Is NCT02704260 still recruiting?

NCT02704260 is currently completed. Last updated 1 November 2017.

Last reviewed 2017-11-01 · How we verify

NCT02704260: GOSSER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Genetic of SportS Induced Endofibrotic Remodeling

Completed NA Last updated 1 November 2017

What this trial tests

NA trial testing GENETIC ANALYSIS in Genetic Syndrome in 5 participants. Completed in 2 September 2016.

Timeline

2 March 2016

Primary endpoint
2 September 2016

2 September 2016

Quick facts

Lead sponsor	University Hospital, Angers
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	5
Start date	2 March 2016
Primary completion	2 September 2016
Estimated completion	2 September 2016
Sites	1 location across France

Drugs / interventions tested

GENETIC ANALYSIS

Conditions studied

Genetic Syndrome — all drugs for Genetic Syndrome →

Sponsor

University Hospital, Angers

Who can join

18 and older, any sex, with Genetic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

search for a genetic cause of vascular endofibrose

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Genetic Syndrome

Currently open trials in the same condition.

NCT06666777 — Speech Therapy and Parenting for Early Socio-communicAtive sKills · NA · recruiting
NCT03967743 — Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders · recruiting

Other University Hospital, Angers trials

Trials by the same sponsor.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07470294 — Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Popula · not yet recruiting
NCT07409597 — Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease · NA · not yet recruiting
NCT07468565 — Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES) · not yet recruiting
NCT07452952 — Relationship Between the Level of Positive End-expiratory Pressure and Venous Congestion During Acute Respiratory Distre · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02704260 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Angers
Last refreshed: 1 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02704260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing